Clean Chemistry recently announced the hiring of Jeff Ballew as its new Vice President of Strategy and Marketing. Jeff comes from a solid industrial water treatment background and most recently held the position of Senior Director of Marketing and Strategy at Evoqua. He has held similar positions at Solenis, Honeywell and GE Water & Process Technologies. Jeff has a BS in Civil Engineering from Drexel University and a Marketing MBA from La Salle University.
“I’m very excited to be part of the Clean Chemistry team. We have a world class organization and a very differentiated offering; it will be exciting to grow our business in new strategic markets,” Ballew commented.
Nick Gardiner, Clean Chemistry President added. “We are excited to have Jeff on our leadership team in this new position. Clean Chemistry continues to look for new markets where our patented PeroxyMAX™ Oxidation Technology brings smarter technology, enhanced automation, data driven quality control and adaptable chemical dosing to new markets. Jeff will be key to identifying and entering these markets.”
PeroxyMAX™ is a patented liquid oxidant, registered with the EPA as a biocide, and formulated to generate large quantities of reactive oxygen species (ROS) for a wide range of uses. This advanced, unique, oxidation technology is at the heart of Clean Chemistry’s treatment solutions. Customers across a wide range of industries benefit from improved safety, performance and efficiency while reducing environmental impact with net cost savings.
About Clean Chemistry
Founded in 2012, Clean Chemistry is committed to customer-inspired innovation and continuous growth. PeroxyMAX, Clean Chemistry’s foundational oxidant technology, was discovered, optimized and commercialized in-house for use in multiple industries. We currently provide full cycle water treatment solutions for the oil and gas industry, cooling water treatment, pulp and paper industry and more. In every industry we serve, Clean Chemistry strives to provide sustainable, customizable, and smart solutions for difficult treatment problems.